Dr. Fang is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
PO Box 51173
Irvine, CA 92619
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Internal Medicine, 1996 - 1999- UCLA David Geffen School of Medicine/UCLA Medical CenterInternship, Internal Medicine, 1996 - 1997
David Geffen School of Medicine at UCLAClass of 1996, MD
Stanford UniversityBA
Certifications & Licensure
CA State Medical License 1998 - 2025
Publications & Presentations
PubMed
- 73 citationsSingle‐ and Multiple‐Dose Pharmacokinetics and Absolute Bioavailability of TedizolidShawn Flanagan, Edward Fang, Kelly A. Muñoz, Sonia L. Minassian, Philippe Prokocimer
Pharmacotherapy. 2014-09-01 - 283 citationsTedizolid Phosphate vs Linezolid for Treatment of Acute Bacterial Skin and Skin Structure Infections: The ESTABLISH-1 Randomized TrialPhilippe Prokocimer, Carisa De Anda, Edward Fang, Purvi Mehra, Anita Das
JAMA. 2013-02-13 - 236 citationsTedizolid for 6 days versus linezolid for 10 days for acute bacterial skin and skin-structure infections (ESTABLISH-2): a randomised, double-blind, phase 3, non-inferi...Gregory J. Moran, Edward Fang, G. Ralph Corey, Anita Das, Carisa De Anda
The Lancet. Infectious Diseases. 2014-08-01
Press Mentions
Pet Wellness Center in Murrieta Offers After-Hours Emergency ServicesApril 2nd, 2021
MicuRx Pharmaceuticals Reports Positive Top-Line Results from a US Phase 2 ABSSSI Clinical Trial of Novel Antibiotic Contezolid AcefosamilSeptember 9th, 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
